Oxford Immunotec Global
Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company. The Companys T-SPOT technology platform allows the Company to measure the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases. T cells are a central component of the human bodys immune system, and are implicated in the control and progression of many medical conditions, including certain types of infectious diseases, cancers and autoimmune diseases. The initial product it has developed using its T-SPOT technology platform is its T-SPOT.TB test, which is used to test for latent Tuberculosis (TB) infection (LTBI). In August 2014, the Company acquired Boulder Diagnostics Inc.